As a senior leader in pharmaceutical development and manufacturing, you know that keeping up-to-date on industry trends is critical to maintaining competitive edge. But do you know how to actively drive these trends and apply them to your manufacturing processes? Are you collaborating with the right stakeholders in order to expand your capabilities and bring your innovation strategy to life?

In this webinar series, three subject matter experts will share their perspective on the future of the industry and provide specific case examples that demonstrate how collaboration enables trends that are shaping the future pharmaceutical manufacturing landscape. The presenters will specifically explore trends like next generation bioprocessing and expansion into emerging markets and present strategies for successful implementation that will reduce costs and timelines and increase productivity.

	April 26, 2017 – Now Available for On-Demand Viewing In the first webinar “How Collaboration Enables Future Trends in Pharmaceutical Manufacturing”, Dr. Helge Berg shares how to harness the power of education and collaboration to enable process intensification and manufacturing flexibility while reducing risk and increasing speed-to-market.Specific points include: Understanding future trends in the pharmaceutical industry and how to apply these to your process Exploring the use of regional M Lab™ Collaboration Centers as your key to expanding in emerging markets such as APAC Leveraging co-development and training to test new technologies and applications with a specific focus on single-use and next generation processing
	May 31, 2017 – Now Available for On-Demand Viewing In this webinar, “Case study: Industry Collaboration Makes Next Generation Biopharmaceutical Processing a Reality,” Merrilee Whitney presents a concrete case study of a successful international industry and academia consortium consigned to develop a next generation downstream bioprocessing will be discussed.You will get insights into: Trends and drivers leading to the emerging paradigm shift towards continuous bioprocessing How an EU-funded industry collaboration successfully develops a completely new next generation downstream platform New process intensification technologies enabling cost savings and increasing productivity
	June 28, 2017 – Now Available for On-Demand Viewing In this webinar, “How Collaboration Fosters Growth and Minimizes Risk in Emerging Pharmaceutical Markets,” Dr. Bala Raghunath, MilliporeSigma’s leading expert on biopharmaceutical purification processes, shares various considerations biopharma companies should factor into their plans to manage risk while expanding their drug pipeline and geographical footprint into emerging markets.The presentation explores: Opportunities and challenges biopharmaceutical companies face when entering and/or expanding in emerging markets The integral role of partnership and the use of M Lab™ Collaboration Centers to explore opportunities, expand geographic footprint and mitigate risk in emerging markets Strategies for using single-use technologies and next generation processing to address emerging market production needs while reducing risk, capital investment, and timelines

Transcripts of these presentations are available in this Special Report.